Trials / Conditions / Agammaglobulinemia

Agammaglobulinemia

9 registered clinical trials studyying Agammaglobulinemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency NCT06954441	On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.	Phase 3
Completed	Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) NCT01581593	Kedrion S.p.A.	Phase 3
Completed	Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency NCT00520494	CSL Behring	Phase 4
Completed	Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) NCT00322556	CSL Behring	Phase 3
Completed	Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) NCT00168012	CSL Behring	Phase 3
Completed	Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) NCT00168025	CSL Behring	Phase 3
Completed	Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients NCT00220766	Grifols Therapeutics LLC	Phase 3
Completed	Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solutio NCT00161993	Baxalta now part of Shire	Phase 2
Completed	Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin NCT00661401	Federal University of São Paulo	N/A